Azelaic acid gel 15%: Clinical versatility in the treatment of rosacea

James Q. Del Rosso, Eric W. Baum, Zoe Diana Draelos, Boni E. Elewski, Alan B. Fleischer, Lenore S. Kakita, Diane Thiboutot

Research output: Contribution to journalReview article

14 Scopus citations

Abstract

There are numerous proposed but contested components involved in the pathophysiology of rosacea, including inflammatory mediators, reactive oxygen species (ROS) released by neutrophils, and microbial components. Ideal comprehensive rosacea management should address these components. Azelaic acid (AzA), a naturally occurring substance, has many proposed mechanisms of action - antimicrobial, anti-inflammatory/ antioxidant, and keratinolytic - that address the proposed components of rosacea pathophysiology and has demonstrated efficacy in subtype 2 rosacea. In a roundtable discussion, information leaders discussed the pathophysiology of rosacea and other issues of importance to successful rosacea management, such as skin care regimens, quality of life (QOL), and compliance.

Original languageEnglish (US)
Pages (from-to)6-19
Number of pages14
JournalCutis
Volume78
Issue number5 SUPPL.
Publication statusPublished - Nov 1 2006

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Del Rosso, J. Q., Baum, E. W., Draelos, Z. D., Elewski, B. E., Fleischer, A. B., Kakita, L. S., & Thiboutot, D. (2006). Azelaic acid gel 15%: Clinical versatility in the treatment of rosacea. Cutis, 78(5 SUPPL.), 6-19.